The purpose of this paper is to critically examine the inconsistencies of currently published data, examine the appropriateness of the current guidelines and to further educate anesthesiologists on the importance of informed perioperative assessment and management of these patients
doi: 10.1128/spectrum.02152-23 205 KontoyiannisD
This increases the risk of hormone imbalance, resistance, mood disorders, liver damage, and other related side effects
H tr trong iu tr vim ty cp: glutathion c th c hiu qu trong vic bo tn cc chc nng ca cc c quan khi s tn cng ca cht trung gian ha hc ca phn ng vim
Bezin, J., Gouverneur, A., Pnichon, M., Mathieu, C., Garrel, R., Hillaire-Buys, D., Pariente, A., & Faillie, J
one common approach began at 0.5 mg once weekly , with incremental increases at approximately four-weekly intervals up to target maintenance doses of 4 mg, 8 mg, or 12 mg once weekly